Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

The role of targeted agents in adjuvant therapy for non-small cell lung cancer.

Kelly K

University of Colorado Health Sciences Center, PO Box 6511, Aurora, CO 80010, USA. karen.kelly@uchsc.edu

The recent survival benefit of adjuvant chemotherapy in early stage non-small cell lung cancer provides optimism for the future success of targeted therapy in this setting. It is important that we begin to explore molecularly targeted agents in the adjuvant arena, but how best to accomplish this in the face of these new findings presents a challenge. Criteria for selecting promising targeted therapies and optimal trial designs to evaluate them expeditiously in the adjuvant setting are clearly needed.

Published 7 July 2005 in Clin Cancer Res, 11(13): 5027s-5029s.
Full-text of this article is available online (may require subscription).

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.